Table 2 Treatment results in tumors with a depth of ≥5 mm versus < 5 mm
From: 106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
| Tumor depth (apical height) | < 5 mm | ≥5 mm | p-Value | ||
|---|---|---|---|---|---|
| Patient number | 27 | 12 | |||
| Tumor recurrence | 2 (7.4%) | 3 (25%) | 0.129 | ||
| Retinopathy | 9 (33.3%) | 2 (16.7%) | 0.286 | ||
| Optic neuropathy | 3 (11.1%) | 1 (8.3%) | 0.792 | ||
| Cataract of treated eye | 15 (55.6%) | 6 (50%) | 0.748 | ||
| Cataract both sides | 12 (44.4%) | 4 (33.3%) | 0.515 | ||
| Hemorrhage | 1 (3.7%) | 0 | 0.499 | ||
| Metastasis | 1 (3.7%) | 4 (33.3%) | 0.011 | ||
| Visual acuity | initial | posttreatment | initial | posttreatment | |
| > 20/40 | 15 (55.5%) | 10 (37.0%) | 8 (66.7%) | 2 (16.7%) | |
| 20/40–20/200 | 11 (40.7%) | 8 (29.6%) | 4 (33.3%) | 6 (50%) | |
| < 20/200 | 1 (3.7%) | 9 (33.3%) | 0 | 4 (33.3%) | |